Protect Patients from Costly Care Act

The Protect Patients from Costly Care Act would repeal two provisions from Public Law 119–21: one that modified Medicaid cost-sharing requirements and another that excluded certain orphan drugs from the Medicare Drug Price Negotiation Program. By repealing these changes, the bill would restore prior rules under the Social Security Act, effectively reversing recent adjustments to Medicaid patient costs and expanding Medicare’s ability to negotiate prices for orphan drugs. The bill affects Medicaid beneficiaries and participants in the Medicare Drug Price Negotiation Program, particularly those impacted by cost-sharing rules and orphan drug pricing exclusions. It also rescinds funding…

No official summary is available here. This one was written by AI from the bill’s text.